Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Cabana vs myRocky

Cabana
Graded #411

Higher grade

vs+5.100000000000001
myRocky
Graded #487

Lower grade

The verdict

Cabana takes it — 56.5/100 to 51.4/100.

Cabana grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Concierge prescription-wellness brand (Cabana LLC) offering compounded GLP-1 weight loss — semaglutide injection, semaglutide tablet, and tirzepatide injection — through a membership program with a…

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueCabana +11
45
34
Dose & formulationCabana +11
64
53
Clinical oversightCabana +12
76
64
Labs & monitoringEven
52
52
FulfillmentmyRocky +5
65
70
Contract termsmyRocky +21
20
41
Cabana · left barmyRocky · right bar

The numbers

MetricCabanamyRocky
WeighScore56.5/10051.4/100
GradeCC
Scorecard rank#411#487
SemaglutideNot disclosedNot disclosed
TirzepatideNot disclosedNot disclosed
CoverageCoverage not publishedCoverage not published
Brand-name accessYesYes
Oral / sublingualYesInjection only
Cabana

Graded #411 · C

Strengths

  • Compounded semaglutide (injection + oral tablet) and tirzepatide injection
  • Membership includes the prescription, provider care, and free shipping — no insurance needed
  • Concierge support model with a dedicated point of contact
  • Async online assessment with licensed-provider review and fast approval

Where it loses points

  • Pricing is not disclosed publicly — only shown after the online assessment
  • Membership fee is non-refundable once paid
  • Compounding pharmacy is not publicly named
myRocky

Graded #487 · C

Strengths

  • Brand-name FDA-approved GLP-1s (Ozempic, Mounjaro, Wegovy) on one platform — no compounded-product risk
  • LegitScript Approved
  • 42-state coverage with an 8-state expansion roadmap published
  • Multi-product platform for patients managing GLP-1 plus sexual health, hair loss, or mental health on one subscription

Where it loses points

  • Expensive stacked fees: $99 consult + $99/mo program fee + ~$1,409/mo medication = ~$1,508/mo
  • Canadian incorporation (Rocky Health Inc., Mississauga, ON) — verify your state's prescriber holds an active US license
  • Listed pharmacy is a Canadian community pharmacy; US-fulfillment supply chain not transparent
  • Brand-only — no compounded option for cost-sensitive patients
  • $1,409/mo Ozempic is near retail; compare NovoCare ($349/mo Wegovy pen) or LillyDirect ($449–$699/mo Zepbound)

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard